Astec LifeSciences has announced significant changes in its board of directors, including the retirement of Mr. Nadir Godrej as Chairperson and Director, effective 13th April, 2026. Mr. Godrej’s departure marks the end of an era, as he steps down after providing invaluable guidance and leadership to the company.
The board has expressed its deepest appreciation for Mr. Godrej’s contributions during his tenure. In his place, Mr. Vishal Sharma has been appointed as the new Chairperson and Additional Director (Non-Executive, Non-Independent), subject to shareholder approval. Mr. Sharma’s appointment is effective from the close of business hours on the same date.
Mr. Vishal Sharma brings a wealth of experience to the role, having served as Executive Director and Chief Executive Officer (Chemicals) at Godrej Industries Limited, the ultimate holding company of Astec LifeSciences. With 30 years of experience in the specialty and process chemicals sector, Mr. Sharma is well-versed in both operational and strategic roles across five continents.
In addition to Mr. Sharma’s appointment, the company has also noted the resignation of Mr. Burjis N. Godrej as Managing Director. Mr. Burjis Godrej has expressed a desire to focus more on Godrej Agrovet Limited, the parent company. However, he will continue to serve on the board as an Additional Non-Executive Director, pending shareholder approval.
These changes reflect Astec LifeSciences’ commitment to maintaining strong leadership and continuity at the board level, ensuring the company’s strategic objectives are met while fostering growth and innovation.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).